Enzalutamide
Pfizer,Astellas
['prostate', 'brca', 'docetaxel']
patients with prostate cancer with germline or somatic #brca 1 and 2 have worse pfs and os regardless of first tx choice (arsi or docetaxel) ongoing trials looking at parpi &amp; other txs to improve outcomes for these patients
- by #asco23 
GU Oncologist | 🇨🇦 GU & NOLA Heme/Onc Alumni | Interested in GU, Immuno Onc & Med Ed | @ASCO Featured Voice | @TwoOncDocs podcast